tretinoin 10 MG Oral Capsule
- RxCUI
- 199159
- RxNorm name
- tretinoin 10 MG Oral Capsule
- Display name
- Tretinoin (Oral Pill)
- Full name
- tretinoin 10 MG Oral Capsule
- Term type
- SCD
- Status
- Active
- Strength
- 10 mg
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-11-04 11:30:27
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| tretinoin | 10 MG / 1 EACH | tretinoin | tretinoin |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| tretinoin | 10753 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | tretinoin 10 MG Oral Capsule | 1 | NAMES |
| RxNorm Name | tretinoin 10 MG Oral Capsule | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 5 | CODES | |
| RxCUI | 199159 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0904-6867-04 | 0904-6867 | Tretinoin Tretinoin | Major Pharmaceuticals | ANDA201687 |
| 10370-268-01 | 10370-268 | Tretinoin Tretinoin | Par Health USA, LLC | ANDA201687 |
| 68084-075-21 | 68084-075 | Tretinoin Tretinoin | American Health Packaging | ANDA201687 |
| 68462-792-01 | 68462-792 | Tretinoin Tretinoin | Glenmark Pharmaceuticals Inc., USA | ANDA208279 |
| 72162-1220-1 | 72162-1220 | Tretinoin Tretinoin | Bryant Ranch Prepack | ANDA201687 |
| 72162-1220-3 | 72162-1220 | Tretinoin Tretinoin | Bryant Ranch Prepack | ANDA201687 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA201687 | 0904-6867 | Tretinoin Tretinoin | ANDA | Major Pharmaceuticals |
| ANDA208279 | 68462-792 | Tretinoin Tretinoin | ANDA | Glenmark Pharmaceuticals Inc., USA |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tretinoin | TRETINOIN | Par Health USA, LLC | 9c4ae9d9-c2a0-4995-a27a-e3f0f0284db9 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 10370-268-01 10370-268 10370026801 199159 |
| Tretinoin | TRETINOIN | Major Pharmaceuticals | 045258e2-5efb-4147-bf74-4c43af04dccc | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 0904-6867-04 0904-6867 00904686760 00904686704 199159 |
| Tretinoin | TRETINOIN | Glenmark Pharmaceuticals Inc., USA | 264138c1-9e5f-45ef-be87-79ca97c989d9 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 68462-792-01 68462-792 68462079201 199159 |
| Tretinoin | TRETINOIN | American Health Packaging | b22d5a07-623a-4645-b87d-a151b86da8d5 | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | 68084-075-21 68084-075 68084007521 68084007511 199159 |
| Tretinoin | TRETINOIN | Bryant Ranch Prepack | 7a7974c7-8b6c-41ae-9a48-a08a1439087a | 2024-07-16 | Boxed warning, Warnings, Adverse reactions | 72162-1220-3 72162-1220-1 72162-1220 72162122003 72162122001 199159 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7a7974c7-8b6c-41ae-9a48-a08a1439087a | tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD] | 2 | 101 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | 20240716 |
| 9c4ae9d9-c2a0-4995-a27a-e3f0f0284db9 | tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD] | 2 | 17 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | 20260310 |
| 045258e2-5efb-4147-bf74-4c43af04dccc | tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD] | 2 | 8 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | 20250415 |
| b22d5a07-623a-4645-b87d-a151b86da8d5 | tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD] | 2 | 7 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | 20251022 |
| 264138c1-9e5f-45ef-be87-79ca97c989d9 | tretinoin 10 MG Oral Capsule [PSN] · tretinoin 10 MG Oral Capsule [SCD] | 2 | 6 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | 20260130 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 9c4ae9d9-c2a0-4995-a27a-e3f0f0284db9 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Par Health USA, LLC | 20260820 |
| 045258e2-5efb-4147-bf74-4c43af04dccc | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Major Pharmaceuticals | 20260526 |
| 9c4ae9d9-c2a0-4995-a27a-e3f0f0284db9 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Par Health USA, LLC | 20260310 |
| 264138c1-9e5f-45ef-be87-79ca97c989d9 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Glenmark Pharmaceuticals Inc., USA | Douglas Manufacturing Limited | 20260130 |
| b22d5a07-623a-4645-b87d-a151b86da8d5 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | American Health Packaging | 20251022 |
| 045258e2-5efb-4147-bf74-4c43af04dccc | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Major Pharmaceuticals | 20250415 |
| 0f81f505-a962-414e-8612-c3ef3b159e9a | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Teva Pharmaceuticals USA, Inc. | 20241216 |
| 264138c1-9e5f-45ef-be87-79ca97c989d9 | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Glenmark Pharmaceuticals Inc., USA | Douglas Manufacturing Limited | 20241129 |
| b22d5a07-623a-4645-b87d-a151b86da8d5 | Tretinoin Capsules 8207521/0320 Rx only | American Health Packaging | 20241029 |
| 1e29818c-1937-4e39-957a-4017fa9c6bdc | These highlights do not include all the information needed to use TRETINOIN safely and effectively. See full prescribing information for TRETINOIN. TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | H2-Pharma, LLC | CHEPLAPHARM Arzneimittel GmbH | 20241014 |
| 7a7974c7-8b6c-41ae-9a48-a08a1439087a | These highlights do not include all the information needed to use TRETINOIN CAPSULES safely and effectively. See full prescribing information for TRETINOIN CAPSULES . TRETINOIN capsules, for oral use Initial U.S. Approval: 1995 | Bryant Ranch Prepack | 20240716 |
| 00892887-ad81-414d-a388-08716235fa2c | TRETINOIN Capsules | Bryant Ranch Prepack | 20240111 |
| 844941d4-f557-42cf-b7fa-5bd7574925f6 | Tretinoin capsules | Bryant Ranch Prepack | 20240110 |
| d8b55a7c-4d05-08b0-e053-2995a90ae42c | Tretinoin Capsules Rx Only | AvKARE | 20240110 |
| 6f8c2985-0241-5ebf-7ed4-4bd9a4ead9c9 | Tretinoin Capsules | AvKARE | 20220117 |
| a8d6a61e-7a8c-4219-85c1-eb65062d01f7 | National Council for Prescription Drug Programs | 20130213 | |
| d27199bb-6cac-49cd-b2ad-99ef40ead23d | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | L01XF | Retinoids for cancer treatment | ATC1-4 | tretinoin | |
| ATC | D10AD | Retinoids for topical use in acne | ATC1-4 | tretinoin | |
| FDASPL | D012176 | Retinoids | CHEM | has_chemical_structure | tretinoin |
| FDASPL | N0000175607 | Retinoid | EPC | has_epc | tretinoin |
| MEDRT | D010226 | Parabens | CHEM | ci_chemclass | tretinoin |
| MEDRT | D014212 | Tretinoin | CHEM | has_ingredient | tretinoin |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | tretinoin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | tretinoin |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | tretinoin |
| MEDRT | D017495 | Hyperpigmentation | DISEASE | may_treat | tretinoin |
| MEDRT | D015473 | Leukemia, Promyelocytic, Acute | DISEASE | may_treat | tretinoin |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | tretinoin |
| MEDRT | N0000000085 | Receptor Interactions | MOA | has_moa | tretinoin |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | tretinoin |
| MEDRT | N0000175676 | Decreased Epithelial Proliferation | PE | has_pe | tretinoin |
| MEDRT | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | tretinoin |
| MEDRT | N0000009979 | Decreased Sebaceous Gland Quantity | PE | has_pe | tretinoin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 10 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA201687 |
| CODES | ANDA | ANDA208279 |
| CODES | SNOMEDCT | 327390008 |
| CODES | VUID | 4005223 |
| NAMES | Prescribable Synonym | tretinoin 10 MG Oral Capsule |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |